Search

Bruck Kifle

Examiner (ID: 2332)

Most Active Art Unit
1624
Art Unit(s)
1202, 1624, 1611, 1622
Total Applications
3434
Issued Applications
2601
Pending Applications
222
Abandoned Applications
651

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7020102 [patent_doc_number] => 20050222121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Atypical antipsychotic agents having low affinity for the D2 receptor' [patent_app_type] => utility [patent_app_number] => 11/031352 [patent_app_country] => US [patent_app_date] => 2005-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15123 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222121.pdf [firstpage_image] =>[orig_patent_app_number] => 11031352 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/031352
Atypical antipsychotic agents having low affinity for the D2 receptor Jan 9, 2005 Abandoned
Array ( [id] => 6983866 [patent_doc_number] => 20050153936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders' [patent_app_type] => utility [patent_app_number] => 11/030043 [patent_app_country] => US [patent_app_date] => 2005-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2617 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153936.pdf [firstpage_image] =>[orig_patent_app_number] => 11030043 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/030043
Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders Jan 6, 2005 Issued
Array ( [id] => 806744 [patent_doc_number] => 07419979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one' [patent_app_type] => utility [patent_app_number] => 10/584473 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8904 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419979.pdf [firstpage_image] =>[orig_patent_app_number] => 10584473 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584473
Derivatives of 6-{4-[4-(1H-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one Jan 4, 2005 Issued
Array ( [id] => 7597601 [patent_doc_number] => 07618976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Methods for the production of sildenafil base and citrate salt' [patent_app_type] => utility [patent_app_number] => 11/030545 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5314 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618976.pdf [firstpage_image] =>[orig_patent_app_number] => 11030545 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/030545
Methods for the production of sildenafil base and citrate salt Jan 4, 2005 Issued
Array ( [id] => 5515436 [patent_doc_number] => 20090215743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Tricyclic benzazepine derivatives and their use' [patent_app_type] => utility [patent_app_number] => 10/586023 [patent_app_country] => US [patent_app_date] => 2004-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28730 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215743.pdf [firstpage_image] =>[orig_patent_app_number] => 10586023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586023
Tricyclic benzazepine derivatives and their use Dec 30, 2004 Abandoned
Array ( [id] => 6939800 [patent_doc_number] => 20050113363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Hydroxyalkanoylaminolactams and related structures as inhibitors of A beta protein production' [patent_app_type] => utility [patent_app_number] => 11/024377 [patent_app_country] => US [patent_app_date] => 2004-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46779 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113363.pdf [firstpage_image] =>[orig_patent_app_number] => 11024377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/024377
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production Dec 27, 2004 Issued
Array ( [id] => 535360 [patent_doc_number] => 07173026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents' [patent_app_type] => utility [patent_app_number] => 11/024240 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3282 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173026.pdf [firstpage_image] =>[orig_patent_app_number] => 11024240 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/024240
Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents Dec 26, 2004 Issued
Array ( [id] => 5904881 [patent_doc_number] => 20060047113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Metal oxide-containing kenyaite catalyst, method for preparing the same, and method for preparing epsilon-caprolactam using the same' [patent_app_type] => utility [patent_app_number] => 11/022250 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4264 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20060047113.pdf [firstpage_image] =>[orig_patent_app_number] => 11022250 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022250
Metal oxide-containing kenyaite catalyst, method for preparing the same, and method for preparing ε-caprolactam using the same Dec 22, 2004 Issued
Array ( [id] => 7105435 [patent_doc_number] => 20050107418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Macrolides' [patent_app_type] => utility [patent_app_number] => 11/020860 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2700 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107418.pdf [firstpage_image] =>[orig_patent_app_number] => 11020860 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/020860
Macrolides Dec 22, 2004 Issued
Array ( [id] => 411691 [patent_doc_number] => 07282493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-16 [patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/022057 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 38690 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/282/07282493.pdf [firstpage_image] =>[orig_patent_app_number] => 11022057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022057
Analogs of benzoquinone-containing ansamycins and methods of use thereof Dec 22, 2004 Issued
Array ( [id] => 750064 [patent_doc_number] => 07022690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Carboxylic acid substituted heterocycles, derivatives thereof and methods of use' [patent_app_type] => utility [patent_app_number] => 11/020751 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20454 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022690.pdf [firstpage_image] =>[orig_patent_app_number] => 11020751 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/020751
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use Dec 22, 2004 Issued
Array ( [id] => 817155 [patent_doc_number] => 07410963 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/582131 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 31833 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410963.pdf [firstpage_image] =>[orig_patent_app_number] => 10582131 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582131
Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof Dec 22, 2004 Issued
Array ( [id] => 425183 [patent_doc_number] => 07271165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/020870 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32582 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271165.pdf [firstpage_image] =>[orig_patent_app_number] => 11020870 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/020870
Rifamycin analogs and uses thereof Dec 21, 2004 Issued
Array ( [id] => 4977949 [patent_doc_number] => 20070219182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Keto Lactam Compounds and Use Thereof' [patent_app_type] => utility [patent_app_number] => 10/582285 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35026 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219182.pdf [firstpage_image] =>[orig_patent_app_number] => 10582285 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/582285
Keto lactam compounds and use thereof Dec 9, 2004 Issued
Array ( [id] => 6997411 [patent_doc_number] => 20050137189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/008597 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16364 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137189.pdf [firstpage_image] =>[orig_patent_app_number] => 11008597 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/008597
Rifamycin analogs and uses thereof Dec 8, 2004 Issued
Array ( [id] => 5890028 [patent_doc_number] => 20060276478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Pyrazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/581775 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12813 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276478.pdf [firstpage_image] =>[orig_patent_app_number] => 10581775 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581775
Pyrazolopyrimidines Dec 7, 2004 Abandoned
Array ( [id] => 5113624 [patent_doc_number] => 20070197540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Pyrazolopyrimidines' [patent_app_type] => utility [patent_app_number] => 10/581776 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15674 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197540.pdf [firstpage_image] =>[orig_patent_app_number] => 10581776 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581776
Pyrazolopyrimidines Dec 7, 2004 Abandoned
Array ( [id] => 7200376 [patent_doc_number] => 20050165002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type' [patent_app_type] => utility [patent_app_number] => 11/005224 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6949 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165002.pdf [firstpage_image] =>[orig_patent_app_number] => 11005224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005224
Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type Dec 5, 2004 Issued
Array ( [id] => 418823 [patent_doc_number] => 07276495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Substituted lactams as inhibitors of Aβ protein production' [patent_app_type] => utility [patent_app_number] => 11/005573 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35160 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276495.pdf [firstpage_image] =>[orig_patent_app_number] => 11005573 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005573
Substituted lactams as inhibitors of Aβ protein production Dec 5, 2004 Issued
Array ( [id] => 7188051 [patent_doc_number] => 20050192269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds' [patent_app_type] => utility [patent_app_number] => 11/002951 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99296 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20050192269.pdf [firstpage_image] =>[orig_patent_app_number] => 11002951 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/002951
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds Dec 2, 2004 Abandoned
Menu